201 related articles for article (PubMed ID: 22762156)
1. Reproductive factors and breast cancer risk in relation to hormone receptor and menopausal status in Japanese women.
Kawai M; Kakugawa Y; Nishino Y; Hamanaka Y; Ohuchi N; Minami Y
Cancer Sci; 2012 Oct; 103(10):1861-70. PubMed ID: 22762156
[TBL] [Abstract][Full Text] [Related]
2. Anthropometric factors, physical activity, and breast cancer risk in relation to hormone receptor and menopausal status in Japanese women: a case-control study.
Kawai M; Kakugawa Y; Nishino Y; Hamanaka Y; Ohuchi N; Minami Y
Cancer Causes Control; 2013 May; 24(5):1033-44. PubMed ID: 23494727
[TBL] [Abstract][Full Text] [Related]
3. Alcohol Consumption and Breast Cancer Risk According to Hormone Receptor Status in Japanese Women: A Case-Control Study.
Takizawa Y; Kawai M; Kakugawa Y; Nishino Y; Ohuchi N; Minami Y
Tohoku J Exp Med; 2018 Jan; 244(1):63-73. PubMed ID: 29353824
[TBL] [Abstract][Full Text] [Related]
4. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study.
John EM; Koo J; Phipps AI; Longacre TA; Kurian AW; Ingles SA; Wu AH; Hines LM
Breast Cancer Res; 2024 May; 26(1):88. PubMed ID: 38822357
[TBL] [Abstract][Full Text] [Related]
5. Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study.
Chung S; Park SK; Sung H; Song N; Han W; Noh DY; Ahn SH; Yoo KY; Choi JY; Kang D
Breast Cancer Res Treat; 2013 Aug; 140(3):557-65. PubMed ID: 23901017
[TBL] [Abstract][Full Text] [Related]
6. Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case-control study.
Figueroa JD; Davis Lynn BC; Edusei L; Titiloye N; Adjei E; Clegg-Lamptey JN; Yarney J; Wiafe-Addai B; Awuah B; Duggan MA; Wiafe S; Nyarko K; Aitpillah F; Ansong D; Hewitt SM; Ahearn T; Garcia-Closas M; Brinton LA;
Int J Cancer; 2020 Sep; 147(6):1535-1547. PubMed ID: 32068253
[TBL] [Abstract][Full Text] [Related]
7. Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities study.
John EM; Phipps AI; Hines LM; Koo J; Ingles SA; Baumgartner KB; Slattery ML; Wu AH
Int J Cancer; 2020 Oct; 147(7):1808-1822. PubMed ID: 32064598
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking and breast cancer risk in relation to joint estrogen and progesterone receptor status: a case-control study in Japan.
Nishino Y; Minami Y; Kawai M; Fukamachi K; Sato I; Ohuchi N; Kakugawa Y
Springerplus; 2014; 3():65. PubMed ID: 24516791
[TBL] [Abstract][Full Text] [Related]
9. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI
J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227
[TBL] [Abstract][Full Text] [Related]
10. Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study.
Bao PP; Shu XO; Gao YT; Zheng Y; Cai H; Deming SL; Ruan ZX; Su Y; Gu K; Lu W; Zheng W
Am J Epidemiol; 2011 Sep; 174(6):661-71. PubMed ID: 21768404
[TBL] [Abstract][Full Text] [Related]
11. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
12. Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American Women.
Ambrosone CB; Zirpoli G; Hong CC; Yao S; Troester MA; Bandera EV; Schedin P; Bethea TN; Borges V; Park SY; Chandra D; Rosenberg L; Kolonel LN; Olshan AF; Palmer JR
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26085483
[TBL] [Abstract][Full Text] [Related]
13. Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status.
Rosato V; Bosetti C; Negri E; Talamini R; Dal Maso L; Malvezzi M; Falcini F; Montella M; La Vecchia C
Eur J Cancer Prev; 2014 Sep; 23(5):412-7. PubMed ID: 23817433
[TBL] [Abstract][Full Text] [Related]
14. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women.
Islam T; Matsuo K; Ito H; Hosono S; Watanabe M; Iwata H; Tajima K; Tanaka H
Ann Oncol; 2012 Sep; 23(9):2435-2441. PubMed ID: 22328736
[TBL] [Abstract][Full Text] [Related]
15. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.
Ma H; Bernstein L; Pike MC; Ursin G
Breast Cancer Res; 2006; 8(4):R43. PubMed ID: 16859501
[TBL] [Abstract][Full Text] [Related]
16. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
Ritte R; Tikk K; Lukanova A; Tjønneland A; Olsen A; Overvad K; Dossus L; Fournier A; Clavel-Chapelon F; Grote V; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Berrino F; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Buckland G; Molina-Montes E; Chirlaque MD; Ardanaz E; Amiano P; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Wareham N; Khaw KT; Key TJ; Travis RC; Weiderpass E; Dumeaux V; Lund E; Sund M; Andersson A; Romieu I; Rinaldi S; Vineis P; Merritt MA; Riboli E; Kaaks R
BMC Cancer; 2013 Dec; 13():584. PubMed ID: 24321460
[TBL] [Abstract][Full Text] [Related]
17. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.
Li CI; Beaber EF; Tang MT; Porter PL; Daling JR; Malone KE
Breast Cancer Res Treat; 2013 Jan; 137(2):579-87. PubMed ID: 23224237
[TBL] [Abstract][Full Text] [Related]
18. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
20. Reproductive risk factors and breast cancer subtypes: a review of the literature.
Anderson KN; Schwab RB; Martinez ME
Breast Cancer Res Treat; 2014 Feb; 144(1):1-10. PubMed ID: 24477977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
